Paul A Kristiansen

Summary

Affiliation: Norwegian Institute of Public Health
Country: Norway

Publications

  1. doi request reprint Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
    Paul A Kristiansen
    Norwegian Institute of Public Health, University of Oslo, Norway
    Clin Infect Dis 56:354-63. 2013
  2. pmc Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 13:363. 2013
  3. pmc Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Clin Vaccine Immunol 18:435-43. 2011
  4. doi request reprint Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Trans R Soc Trop Med Hyg 106:289-97. 2012
  5. pmc Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    J Clin Microbiol 50:4020-7. 2012
  6. pmc Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine
    Dominique A Caugant
    WHO Collaborating Centre for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    PLoS ONE 7:e46019. 2012

Detail Information

Publications6

  1. doi request reprint Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity
    Paul A Kristiansen
    Norwegian Institute of Public Health, University of Oslo, Norway
    Clin Infect Dis 56:354-63. 2013
    ..It is not known whether MenAfriVac has an impact on NmA carriage...
  2. pmc Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 13:363. 2013
    ..The aim of this study was to genetically characterize meningococcal isolates circulating in Burkina Faso before and up to 13 months after MenAfriVac mass vaccination...
  3. pmc Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Clin Vaccine Immunol 18:435-43. 2011
    ..5-1,2-2/F5-8, belonging to the ST-23 complex (47%). All serogroup A isolates were ST-2859 of the ST-5 complex with P1.20,9/F3-1. This study forms a solid basis for evaluating the impact of MenAfriVac introduction on serogroup A carriage...
  4. doi request reprint Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso
    Paul A Kristiansen
    Norwegian Institute of Public Health, Nydalen, 0403 Oslo, Norway
    Trans R Soc Trop Med Hyg 106:289-97. 2012
    ..The overall N. meningitidis carriage prevalence (3.98%) was probably slightly underestimated and the calculated true prevalence was 4.48%. The components of the presented QC system can easily be implemented in any other laboratory study...
  5. pmc Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    J Clin Microbiol 50:4020-7. 2012
    ..meningitidis carriage and disease epidemiology in Burkina Faso...
  6. pmc Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine
    Dominique A Caugant
    WHO Collaborating Centre for Reference and Research on Meningococci, Norwegian Institute of Public Health, Oslo, Norway
    PLoS ONE 7:e46019. 2012
    ....